Leadership Team
Our leadership team has extensive knowledge in the drug development industry, with the insight and expertise to help you meet your goals
With deep experience across the biopharmaceutical and medical device spectrum, our experts are passionate about supporting small and mid-sized biotechs.
Paula Brown Stafford
CEO
Mark A. Goldberg, M.D.
Chairman
Howard Brand
Chief Financial Officer
Christopher S. Brennan, Esq.
Chief Operating Officer & General Counsel
Steffany Cox
Chief Marketing Officer
Leslie DeVos
President, Regulatory and Drug Development Consulting
David Godwin
Chief Revenue Officer
Katy Moore, Pharm. D., R.Ph.
President, Clinical Pharmacology Modeling and Simulation
Anita Nelsen
President Clinical Trial Operations
Teresa Nunes, M.D., MSC, MBA
Chief Medical Officer
Kim Washburn
Vice President, Quality